Lassa fever resources
PPE washing and drying station Lassa ward Owo
ISARIC is committed to strengthening the evidence base for Lassa fever therapeutics and improving case management. We have initiated a number of activities to address these knowledge gaps, which are conducted alongside a wide-range of partners and collaborators.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Publication library
Visit this section to find ISARIC’s articles, studies and more.
Latest news
Women under 50 had worse long-term outcomes after hospitalisation with COVID-19
Women under 50 and people who experienced severe disease had worse long-term outcomes following hospitalisation with COVID-19.
Key inflammatory markers identified in COVID-19
ISARIC, supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the severity of COVID-19 and distinguish it from severe influenza.
Long COVID: tackling a multifaceted condition requires a multi- disciplinary approach
The Lancet Infectious Diseases published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020.